Update from the scientific panel on antibiotic use in dermatology: Clinical considerations for the dermatologist

Cutis

Volumn 82, Issue 2 SUPPL., 2008, Pages 3-4

  Del Rosso, James Q ^a,b,c,d,e  

^a UNIVERSITY OF NEVADA   (United States)

^b TOURO UNIVERSITY NEVADA   (United States)

^c VALLEY HOSPITAL MEDICAL CENTER   (United States)

^d Mohave Skin and Cancer Clinics   (United States)

^e Las Vegas Skin and Cancer Clinics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; CONFERENCE PAPER; DERMATOLOGY; HUMAN; SKIN DISEASE;

ANTI-BACTERIAL AGENTS; DERMATOLOGY; DRUG RESISTANCE, BACTERIAL; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; SKIN DISEASES;

EID: 51149110731     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Burkhart CG, Burkhart CN, Isham N. Synergistic antimicrobial activity by combining an allylamine with benzoyl peroxide with expanded coverage against yeast and bacterial species. Br J Demotol. 2006; 154: 341-344.
2. Gollnick H, Cunliffe W, Berson D, et al; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49 (suppl 1):S1-S37.
3. Del Rosso JQ. Recently approved systemic therapies for acne vulgaris and rosacea [published correction appears in Cutis. 2007;80:334]. Cutis. 2007;80:113-120.